{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:28:06Z","timestamp":1785583686988,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,13]]},"DOI":"10.7759\/cureus.82161","type":"journal-article","created":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T08:00:51Z","timestamp":1744531251000},"source":"Crossref","is-referenced-by-count":1,"title":["Bilateral Spontaneous Pneumothorax in a Patient With Metastatic Leiomyosarcoma Receiving Pazopanib: A Case Report"],"prefix":"10.7759","author":[{"given":"Maria","family":"Konstantinidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina Chrysanthi","family":"Theocharidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Dimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Emmanouilides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotini","family":"Ampatzidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2017.1351943","article-title":"Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas","volume":"13","author":"Ferrero S","year":"2017","unstructured":"Ferrero S, Leone Roberti Maggiore U, Aiello N, et al.. Pharmacokinetic drug evaluation of pazopanib for the treatment of uterine leiomyosarcomas. Expert Opin Drug Metab Toxicol. 2017, 13:881-9. 10.1080\/17425255.2017.1351943","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2014.02.010","article-title":"Incidence of pneumothorax in advanced and\/or metastatic soft tissue sarcoma patients during pazopanib treatment","volume":"26","author":"Nakano K","year":"2014","unstructured":"Nakano K, Inagaki L, Tomomatsu J, et al.. Incidence of pneumothorax in advanced and\/or metastatic soft tissue sarcoma patients during pazopanib treatment. Clin Oncol (R Coll Radiol). 2014, 26:357. 10.1016\/j.clon.2014.02.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5152\/TurkThoracJ.2018.030118","article-title":"A case report of secondary simultaneous bilateral pneumothorax due to pazopanib treatment","volume":"19","author":"\u00c7elik B","year":"2018","unstructured":"\u00c7elik B, S\u00fcr\u00fcc\u00fc ZP, Y\u0131lmaz V, \u00c7elik HK. A case report of secondary simultaneous bilateral pneumothorax due to pazopanib treatment. Turk Thorac J. 2018, 19:49-51. 10.5152\/TurkThoracJ.2018.030118","journal-title":"Turk Thorac J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2022.100993","article-title":"Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: a case report","volume":"41","author":"Sawayama S","year":"2022","unstructured":"Sawayama S, Murakami R, Aki M, et al.. Efficacy of pazopanib in FGFR1-amplified uterine carcinosarcoma: a case report. Gynecol Oncol Rep. 2022, 41:100993. 10.1016\/j.gore.2022.100993","journal-title":"Gynecol Oncol Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2014.901155","article-title":"Emerging therapeutic targets for synovial sarcoma","volume":"14","author":"Palmerini E","year":"2014","unstructured":"Palmerini E, Paioli A, Ferrari S. Emerging therapeutic targets for synovial sarcoma. Expert Rev Anticancer Ther. 2014, 14:791-806. 10.1586\/14737140.2014.901155","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.9764","article-title":"Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial","volume":"28","author":"Sternberg CN","year":"2010","unstructured":"Sternberg CN, Davis ID, Mardiak J, et al.. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol. 2010, 28:1061-8. 10.1200\/JCO.2009.23.9764","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.12.010","article-title":"A randomised, double-blind phase III study of pazopanib in patients with advanced and\/or metastatic renal cell carcinoma: final overall survival results and safety update","volume":"49","author":"Sternberg CN","year":"2013","unstructured":"Sternberg CN, Hawkins RE, Wagstaff J, et al.. A randomised, double-blind phase III study of pazopanib in patients with advanced and\/or metastatic renal cell carcinoma: final overall survival results and safety update. Eur J Cancer. 2013, 49:1287-96. 10.1016\/j.ejca.2012.12.010","journal-title":"Eur J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2021.1971294","article-title":"A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma","volume":"60","author":"van Meekeren M","year":"2021","unstructured":"van Meekeren M, Bovee JV, van Coevorden F, et al.. A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma. Acta Oncol. 2021, 60:1557-64. 10.1080\/0284186X.2021.1971294","journal-title":"Acta Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2292","article-title":"A comprehensive review of spontaneous pneumothorax complicating sarcoma","volume":"138","author":"Hoag JB","year":"2010","unstructured":"Hoag JB, Sherman M, Fasihuddin Q, Lund ME. A comprehensive review of spontaneous pneumothorax complicating sarcoma. Chest. 2010, 138:510-8. 10.1378\/chest.09-2292","journal-title":"Chest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.51847\/597Cjlr708","article-title":"Review on pneumothorax diagnostic and management approach in emergency department","volume":"11","author":"Almulhim FA","year":"2022","unstructured":"Almulhim FA, Alshahrani MM, Hakami AM, et al.. Review on pneumothorax diagnostic and management approach in emergency department. Int J Pharm Res Allied Sci. 2022, 11:35-9. 10.51847\/597Cjlr708","journal-title":"Int J Pharm Res Allied Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2786-z","article-title":"Risk factors for pneumothorax in advanced and\/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis","volume":"16","author":"Nakano K","year":"2016","unstructured":"Nakano K, Motoi N, Tomomatsu J, et al.. Risk factors for pneumothorax in advanced and\/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis. BMC Cancer. 2016, 16:750. 10.1186\/s12885-016-2786-z","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-47674-4.00079-7","article-title":"Cancer of the kidney","author":"McNamara MA","year":"2020","unstructured":"McNamara MA, Zhang T, Harrison MR, George DJ. Cancer of the kidney. Abeloff's Clinical Oncology (Sixth Edition). Elsevier, Amsterdam, Netherlands; 2020. 1361-81. 10.1016\/B978-0-323-47674-4.00079-7"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1225038","article-title":"Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review","volume":"12","author":"Boudou-Rouquette P","year":"2016","unstructured":"Boudou-Rouquette P, Tlemsani C, Blanchet B, et al.. Clinical pharmacology, drug-drug interactions and safety of pazopanib: a review. Expert Opin Drug Metab Toxicol. 2016, 12:1433-44. 10.1080\/17425255.2016.1225038","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254866","article-title":"Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: a case series analysis","volume":"16","author":"Aiba H","year":"2021","unstructured":"Aiba H, Kimura H, Yamada S, et al.. Different patterns of pneumothorax in patients with soft tissue tumors treated with pazopanib: a case series analysis. PLoS One. 2021, 16:e0254866. 10.1371\/journal.pone.0254866","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60651-5","article-title":"Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"379","author":"van der Graaf WT","year":"2012","unstructured":"van der Graaf WT, Blay JY, Chawla SP, et al.. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2012, 379:1879-86. 10.1016\/S0140-6736(12)60651-5","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1905","article-title":"Spontaneous pneumothoraces and hemothoraces in sarcomas","volume":"9","author":"Ezzeddine F","year":"2017","unstructured":"Ezzeddine F, Jalal S. Spontaneous pneumothoraces and hemothoraces in sarcomas. Cureus. 2017, 9:e1905. 10.7759\/cureus.1905","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3329-4-14","article-title":"Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series","volume":"4","author":"Verschoor AJ","year":"2014","unstructured":"Verschoor AJ, Gelderblom H. Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series. Clin Sarcoma Res. 2014, 4:14. 10.1186\/2045-3329-4-14","journal-title":"Clin Sarcoma Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4858-8","article-title":"Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study","volume":"18","author":"Sabath B","year":"2018","unstructured":"Sabath B, Muhammad HA, Balagani A, et al.. Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study. BMC Cancer. 2018, 18:937. 10.1186\/s12885-018-4858-8","journal-title":"BMC Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/347900-bilateral-spontaneous-pneumothorax-in-a-patient-with-metastatic-leiomyosarcoma-receiving-pazopanib-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T08:00:51Z","timestamp":1744531251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/347900-bilateral-spontaneous-pneumothorax-in-a-patient-with-metastatic-leiomyosarcoma-receiving-pazopanib-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,13]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.82161","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,13]]}}}